ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1190

The Early Renal Profibrotic Phenotype Caused by 5/6 Nephrectomy in Mice Depends on CD11c+ Antigen-Presenting Cells Population

Session Information

  • CKD: Mechanisms - 3
    October 26, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Reyes Osorio, Javier Ignacio, Universidad San Sebastian Facultad de Medicina y Ciencia, Santiago, Providencia, Chile
  • Araos, Patricio A., Universidad Autonoma de Chile - Campus El Llano Subercaseaux, Santiago, San Miguel, Chile
  • Figueroa, Stefanny M., Universidad San Sebastian Facultad de Medicina y Ciencia, Santiago, Providencia, Chile
  • Saez, Javiera, Universidad San Sebastian Facultad de Medicina y Ciencia, Santiago, Providencia, Chile
  • Fuenzalida, Maria Jose, Fundacion Ciencia & Vida, Santiago, Huechuraba, Chile
  • Pacheco, Rodrigo, Fundacion Ciencia & Vida, Santiago, Huechuraba, Chile
  • Amador, Cristián A., Universidad San Sebastian Facultad de Medicina y Ciencia, Santiago, Providencia, Chile

Group or Team Name

  • Laboratory of Renal Physiopathology.
Background

The recruitment and activation of antigen-presenting cells (APC) represent key mechanisms for the pro-inflammatory stages that lead to fibrosis in the progression of chronic kidney disease (CKD). Our revious experimental studies indicate that dendritic cells-like APC (APC-CD11c+) are essential for inflammation, renal dysfunction, and heart fibrosis in mice with hypertensive nephropathy. Although that we have previously demonstrated that APC-CD11c+ would not contribute to the inflammatory processes in the experimental unilateral ureteral obstruction, it is still unknown whether these cells contribute to the renal pro-fibrotic status in a model of CKD with reduction of renal function. Our objective was to determine whether the depletion of APC-CD11c+ prevents the early renal pro-fibrotic status in a 5/6 nephrectomy model (Nx5/6).

Methods

Male CD11c.DOG mice (8-12 wo, n=3-7), which can be depleted of APC-CD11c+ by using diphtheria toxin (DT), underwent to the Nx5/6 or Sham surgery (control) for 5-days. These groups received vehicle (Vh) or DT (8ng/g/d, ip) from the beginning of the experiment, where those animals-DT+ with a reduction >60% of APC-CD11c+ were selected. Biochemical, histological and molecular analyses were performed.

Results

Nx5/6 caused a trend increase in plasma creatinine (p=0.16 vs Sham-Vh), and in blood urea nitrogen (p=0.08 vs Sham-Vh). In addition, Nx5/6 caused a significant increase in renal fibrotic area and was associated with the overexpression in the mRNA for the following pro-fibrotic markers: Collagen (COL)1A1, COL3A1 and Fn-I (p<0.05 vs Sham-Vh), and the pro-inflammatory mediators: Interleukin (IL)-6 and Lipocalin-2 (NGAL). Depletion of APC-CD11c+ in Nx5/6 animals did not alter the plasma parameters analyzed for determining renal function, but it did prevent renal fibrosis (3.79% vs 5.80% Nx5/6-Vh; p<0.05), and the increase of mRNA for COL3A1 (p<0.05). In addition, the use of DT was associated with a lower abundance of COL1A1 and Fn I (p=0.07 and p=0.12, vs Nx5/6-Vh, respectively), without affecting any pro-inflammatory mediator.

Conclusion

APC-CD11c+ depletion prevents the early renal profibrotic phenotype in the Nx5/6 model, providing new background related to the importance of APCs in the early progression of CKD.

Funding

  • Government Support – Non-U.S.